This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
PAPPA / Pappalysin-1 · IHC design guide
Design Immunohistochemistry for PAPPA
Plan PAPPA staining in paraffin sections using the cytoplasmic syncytiotrophoblast pattern seen in placenta (HPA tissue IHC). Start with the catalog antibody at 0.5–1 µg/mL (datasheet: PB9306) and consider secretion when interpreting signal location (UniProt).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
PAPPA Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Trophoblast cytoplasm (HPA tissue IHC); secreted (UniProt) | |
| Staining pattern | Cytoplasmic staining in placental syncytiotrophoblasts (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6.0 HIER, 95–98 °C, 20 min (rule: cytoplasmic / membrane antigen) | |
| Positive control | Placenta | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep fixation conditions consistent across sections. (standard IHC practice; not target-specific) | |
| Caveat | Protein and RNA locations may differ for secreted PAPPA (HPA tissue IHC) | |
| Regulation | High in placenta and pregnancy serum (UniProt) | |
| Isoform / epitope | No listed isoforms; mature chain starts at aa 82 (UniProt) |
Section 1
Recommended PAPPA IHC & IF Protocols
The catalog antibody’s IHC-P protocol is accompanied by four published PAPPA IHC protocols (PMC5353903; PMC10284350; PMC8805841; PMC4599249).
| Sample | Tissue sections; selected-image fixative not specified (standard IHC workflow) |
| Fixation | Image fixative and duration unreported (datasheet PB9306); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat-induced epitope retrieval in citrate buffer, pH 6.0, 20 min at 95–98 °C (standard rule: cytoplasmic / membrane antigen) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% normal serum of the secondary host, 30 min, room temperature (standard) |
| Primary antibody | Rabbit anti-PAPPA, 0.5-1μg/ml (datasheet PB9306) |
| Primary incubation | Overnight at 4 °C (standard) |
| Detection | HRP-polymer secondary, DAB chromogen 5–10 min (standard) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | PAPPA-positive staining in syncytiotrophoblasts - cell body of placenta (HPA tissue IHC: High). HPA tissue profile: Cytoplasmic expression in trophoblastic cells. No signal in the no-primary control. |
💡Decision noteStart with citrate pH 6.0 retrieval at 95–98 °C for 20 min (page antigen retrieval); the published protocols provide conditions to compare (PMC10284350; PMC8805841).
Section 2
What Is the Expected PAPPA Staining Pattern?
PAPPA is secreted and has no transmembrane segment (UniProt Q13219: subcellular location and topology). In placenta, expect cytoplasmic staining in trophoblastic cells, with high staining in syncytiotrophoblast cell bodies (HPA: Enhanced tissue IHC; placenta, High). HPA reports high consistency between staining and RNA expression, while cautioning that the tissue locations of a secreted protein and its RNA can differ (HPA: reliability description).
| Strong staining in placental syncytiotrophoblast cell bodies. | This matches the reported high placental signal and trophoblastic cytoplasmic pattern (HPA: placenta, High; tissue IHC profile). Assess the named cell population rather than treating every stained area of placenta as an equivalent positive result (HPA: cell-specific observation). |
| Predominantly nuclear staining or a crisp, continuous membrane outline. | These are unsupported as the expected pattern: HPA describes trophoblastic cytoplasmic staining, and UniProt describes a secreted protein without a transmembrane segment (HPA: tissue IHC profile; UniProt Q13219: location and topology). Recheck the stained compartment before scoring it as PAPPA. |
| Prominent staining in a cell population reported as undetected. | For example, HPA reports no detection in adipose-tissue adipocytes or bone-marrow hematopoietic cells (HPA: tissue IHC negatives). Such staining warrants a cross-reactivity or endogenous detection-activity check; it alone does not establish PAPPA expression (general IHC practice). |
| Uniform color across tissue and blank areas, obscuring cell boundaries. | This is more consistent with background than the reported cell-specific placental pattern (HPA: tissue IHC profile; general IHC practice). A secreted target can make tissue-level interpretation nuanced, but secretion does not validate uniform slide-wide staining (UniProt Q13219: Secreted). |
| No detectable staining in placental syncytiotrophoblast cell bodies. | The result fails the supplied positive benchmark (HPA: placenta, High). First assess whether the relevant cells are present and whether the run's controls worked (general IHC practice). The supplied sources do not identify a PAPPA-specific cause of signal loss. |
💡Expected PAPPA appearanceA positive placental section shows high cytoplasmic staining in syncytiotrophoblast cell bodies; dominant nuclear, membrane-only, or uniform slide-wide color is suspect (HPA: placenta, High; tissue IHC profile; UniProt Q13219: topology; general IHC practice).
| Placental cell population | HPA localizes high protein staining to syncytiotrophoblast cell bodies; UniProt also reports PAPPA in placental X cells of septa and anchoring villi (HPA: placenta, High; UniProt Q13219: tissue specificity). The two sources describe different evidence, so do not assign an HPA intensity to X cells. |
| Secretion and topology | PAPPA has a signal peptide, is annotated as secreted, and has no transmembrane segment (UniProt Q13219: processing, location and topology). HPA's observed cytoplasmic trophoblastic staining is the slide benchmark; the annotation alone cannot predict where extracellular signal will appear (HPA: tissue IHC profile). |
| Evidence behind the IHC pattern | HPA rates tissue IHC Enhanced, reports high consistency with RNA expression, and lists two antibodies with Enhanced IHC status (HPA: reliability description; HPA001667 and CAB016724). This supports the reported pattern but does not establish fixation sensitivity or a retrieval condition. |
| Tissue-level negative comparisons | HPA reports several specific cell populations as not detected, including adipocytes in adipose tissue and hematopoietic cells in bone marrow (HPA: tissue IHC negatives). UniProt lists lower PAPPA levels in various tissues, including bone marrow; keep cell-specific IHC observations separate from tissue-level expression (UniProt Q13219: tissue specificity). |
| Q: Can ICC-IF establish the expected subcellular pattern? | A: HPA gives no main ICC-IF location or cell-line images, and neither listed antibody has an ICC validation entry (HPA: subcellular record; HPA001667 and CAB016724). Use the placental IHC observation as the supplied staining benchmark, without assigning an IF compartment from these records. |
| Situation | Likely cause | Next action |
|---|---|---|
| Placental syncytiotrophoblasts are unstained. | The sampled section may lack assessable target cells, or the IHC run may have failed; neither possibility is PAPPA-specific (HPA: placenta, High; general IHC practice). | Confirm the cell population on the section and review run controls, antibody dilution, retrieval and detection records (general IHC practice). No PAPPA-specific retrieval setting is supplied. |
| The strongest signal is nuclear. | The distribution conflicts with HPA's cytoplasmic trophoblastic profile; its source cannot be identified from location alone (HPA: tissue IHC profile). | Compare the compartment with the placental positive benchmark and review negative controls and antibody specificity (HPA: placenta, High; general IHC practice). Do not score nuclear signal as the expected result. |
| A membrane-only rim dominates the stain. | A stable membrane pattern is unsupported by the supplied location and topology annotations (UniProt Q13219: Secreted; no transmembrane segment). | Inspect cell-body cytoplasm at suitable magnification and compare with the reported HPA pattern; check controls if the rim persists (HPA: tissue IHC profile; general IHC practice). |
| Reported-negative cell populations stain strongly. | Cross-reactivity or endogenous detection activity is possible; HPA's negative calls apply to the named cell types (HPA: tissue IHC negatives; general IHC practice). | Check a no-primary control and the detection system, then compare the exact cell type with HPA's entry (general IHC practice; HPA: tissue IHC negatives). Avoid calling the whole tissue PAPPA-negative. |
| Brown color is diffuse across tissue and blank areas. | Nonspecific background or detection-system activity is possible (general IHC practice); the HPA placental observation is cell-associated cytoplasmic staining (HPA: tissue IHC profile). | Inspect blank areas and negative controls, then review blocking, washing and detection steps (general IHC practice). Score only signal that can be assigned to the relevant cells. |
| IF shows a pattern that seems different from placental IHC. | The supplied HPA subcellular record lacks ICC-IF images and a main location, so it offers no validated IF pattern for comparison (HPA: subcellular record). | Interpret that IF observation with its own controls and validation; retain the documented placental cytoplasmic IHC pattern as the benchmark for this section (general IF practice; HPA: tissue IHC profile). |
Experiment evidence
IHC & IF images showing PAPPA staining
PB9306 · IHCAnti-PAPP A vendor antibody, PB9306, IHC(P) IHC(P): Human Placenta Tissue
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000182752-PAPPA/tissue/cerebral+cortex#imid_4255600
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000182752-PAPPA/tissue/colon#imid_4255518
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000182752-PAPPA/tissue/liver#imid_4255519
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000182752-PAPPA/tissue/kidney#imid_4255528
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for PAPPA IHC & IF
🧪Run placenta first; syncytiotrophoblast cell bodies should stain (HPA: High in placental syncytiotrophoblast cell bodies). Use adipose tissue as the negative tissue, focusing on adipocytes (HPA: Not detected in adipocytes); on the placenta slide, assess other cell populations and background as internal comparisons without assuming they are PAPPA-negative (HPA: only syncytiotrophoblast cell bodies are listed as High).
Positive control tissue: Placenta (Syncytiotrophoblasts - cell body, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA carries no ICC-IF cell line for PAPPA; derive a cell-line control from the positive tissue's cell type (Syncytiotrophoblasts - cell body) and confirm it by RNA or western blot first.
Technical controls: Include a no-primary, secondary-only control, plus nonimmune IgG matched to the primary antibody’s host species and, for a monoclonal antibody, its isotype (standard IHC practice); use identically processed PAPPA-knockout material as a biological specificity control if available (standard IHC practice). Quench endogenous peroxidase for chromogenic detection and check whether a biotin-based detection system needs endogenous-biotin blocking on placenta (standard IHC practice).
⚠️Feasibility: A target-specific fixation window and its effect on PAPPA staining are unreported in the supplied evidence; the selected PB9306 IHC(P) placenta caption does not state a fixative (selected-SKU caption: fixative not stated). Antigen-retrieval dependency is unreported, and the supplied evidence does not establish whether frozen sections or IF would be easier (selected-SKU caption: IHC(P) only; HPA subcellular: no ICC-IF image cell lines). Because PAPPA is secreted, interpret diffuse extracellular signal cautiously alongside the syncytiotrophoblast cell-body pattern (UniProt Q13219: Secreted; HPA: High in placental syncytiotrophoblast cell bodies).
HPA tissue IHC evidence for PAPPA
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — High consistency between antibody staining and RNA expression data. Secreted protein, tissue location of RNA and protein is expected to differ.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Placenta | Syncytiotrophoblasts - cell body | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced PAPPA IHC Tips
Troubleshoot PAPPA staining in paraffin sections by checking retrieval, tissue handling, cell type, and background before comparing chromogenic signal across samples.
How should I retrieve PAPPA in paraffin sections when placental staining is weak?
Start with citrate buffer at pH 6.0, heated to 95–98 °C for 20 min (page retrieval setting). Run a placenta section alongside the test section because syncytiotrophoblast cell bodies show high PAPPA staining (HPA: placenta tissue IHC). Keep section thickness, cooling, and detection conditions matched while assessing retrieval, so a change in signal can be attributed to that step (standard IHC practice). If staining remains weak, assess whether longer heating improves the expected cell pattern without increasing background (standard IHC practice). Record the retrieval condition used for every comparison (standard IHC practice).
Could fixation explain variable PAPPA staining between paraffin samples?
Target-specific PAPPA sensitivity to fixative type or fixation time is unknown from the supplied evidence (selected PB9306 caption: fixative not stated). Record the fixative, time before fixation, fixation duration, and processing history for each section before comparing staining (standard IHC practice). For a controlled comparison, cut sections at the same thickness and apply the page’s citrate pH 6.0 retrieval for 20 min to all samples (page retrieval setting; standard IHC practice). Compare signal and tissue preservation together, since damaged morphology makes cell-level scoring unreliable (standard IHC practice). Do not assign a PAPPA-specific fixation effect without a controlled comparison (selected PB9306 caption: fixative not stated).
Where should convincing PAPPA staining appear in placental IHC?
Examine trophoblastic cells first: HPA reports cytoplasmic expression and high staining in syncytiotrophoblast cell bodies (HPA: placenta tissue IHC). PAPPA is secreted and has no transmembrane segment, so staining confined to a crisp plasma-membrane rim would need additional validation (UniProt Q13219: subcellular location and topology). Secreted protein may also appear outside producing cells, so record extracellular signal separately from cell-body signal (UniProt Q13219: secreted; HPA: secreted-protein caveat). Compare the pattern with a matched negative control and tissue morphology at the same magnification (standard IHC practice). Avoid calling diffuse extracellular chromogen evidence of expression by the nearest cell without supporting cell-level staining (HPA: secreted-protein caveat).
How can I assess whether an unexpected PAPPA pattern reflects epitope accessibility?
The supplied record lists 0 isoforms, so an isoform-specific explanation is unsupported here (UniProt Q13219: isoforms). PAPPA undergoes signal-peptide and propeptide processing, has 14 listed glycosylation sites, and contains 5 Sushi domains (UniProt Q13219: processing, glycosylation, domains). Those features make the antibody’s mapped epitope relevant, but the supplied PB9306 caption does not identify one (selected PB9306 caption). Ask for epitope information and compare independently validated epitopes on adjacent sections if available (standard IHC practice). Keep citrate pH 6.0 retrieval and detection conditions matched during that comparison (page retrieval setting; standard IHC practice).
How should I investigate a PAPPA IHC pattern with tissue immunofluorescence?
Use IF as a separate validation experiment and compare its cell distribution with chromogenic PAPPA staining in adjacent sections (standard IF/IHC practice). Multiplex PAPPA with an independently validated trophoblast marker because trophoblastic cytoplasm and syncytiotrophoblast cell bodies are the expected placental pattern (HPA: placenta tissue IHC). Choose a fluorophore channel after measuring unstained tissue autofluorescence, then include single-label controls to assess bleed-through (standard IF practice). If the antibody epitope is intracellular, use controlled permeabilisation; if extracellular, test without permeabilisation first (standard IF practice; UniProt Q13219: secreted). The supplied evidence gives no PB9306 IF epitope or IF fixation condition, so optimise those steps empirically (selected PB9306 caption).
What should I check when PAPPA chromogenic staining spreads across the whole section?
Check a no-primary control and the distribution of deposit before increasing antibody concentration (standard IHC practice). Block endogenous peroxidase before chromogenic detection and assess nonspecific secondary-reagent staining with an appropriate control (standard IHC practice). Keep the page’s citrate pH 6.0, 20 min retrieval fixed while adjusting blocking, washes, or detection time one variable at a time (page retrieval setting; standard IHC practice). PAPPA is secreted, so extracellular staining can occur, but uniform deposit across unrelated structures does not establish PAPPA localisation (UniProt Q13219: secreted; standard IHC interpretation). Compare suspected background with the high syncytiotrophoblast cell-body pattern in placenta (HPA: placenta tissue IHC).
How should I score PAPPA staining across placental paraffin sections? ⚠ ANSWER MARKED FOR VERIFICATION
Define the tissue region and score trophoblastic cell bodies separately from extracellular deposit, because HPA reports cytoplasmic trophoblastic expression and PAPPA is secreted (HPA: placenta tissue IHC; UniProt Q13219: secreted). Record percentage of positive target cells and intensity, then calculate an H-score as 1 × weak% + 2 × moderate% + 3 × strong% (standard IHC scoring practice). Normalise cell-based results to the number of evaluable target cells, or report positive area per mm² of evaluable tissue for area-based analysis (standard IHC practice). Apply identical thresholds, imaging settings, and exclusion rules across sections (standard IHC practice). Report extracellular signal separately to preserve the cell-level comparison (HPA: secreted-protein caveat).
How can I distinguish true PAPPA staining from artefact in placenta?
Look for reproducible staining in trophoblastic cytoplasm, especially syncytiotrophoblast cell bodies, alongside preserved morphology (HPA: placenta tissue IHC; standard IHC practice). A solely nuclear or sharply membrane-restricted pattern needs scrutiny because PAPPA is secreted and lacks a transmembrane segment (UniProt Q13219: subcellular location and topology). Compare section edges and necrotic areas with intact central tissue; signal limited to damaged regions is suspect (standard IHC practice). Check the no-primary control for endogenous enzyme or detection-reagent deposit before interpreting chromogen (standard IHC practice). Use the same citrate pH 6.0, 20 min retrieval when repeating questionable samples (page retrieval setting).
Boster reagents
Best PAPPA / Pappalysin-1 IHC Antibodies
PB9306 has real IHC(P) data from human placenta tissue (PB9306 image caption); its listed reactivity is Human (catalog: reactivity).
Real IHC data
Anti-PAPP A/PAPPA Antibody ®
Cat # PB9306
PB9306 is listed for IHC in Human (catalog: applications, reactivity). Its own figure shows IHC(P) on human placenta tissue (PB9306 image caption).
Which to pick: For tissue IHC, choose PB9306 for human paraffin sections based on its own placenta IHC(P) figure; the fixative is unreported (PB9306 image caption). No listed SKU has IF/ICC validation or an IF image (catalog: applications, if_image_alts). No listed SKU has nonhuman reactivity; PB9306 has a Rabbit host and no reported clone (catalog: reactivity, host, clone).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry Q13219 (PAPP1_HUMAN, Pappalysin-1).
- Human Protein Atlas. PAPPA tissue IHC expression (reliability: Enhanced).
- Human Protein Atlas. PAPPA subcellular location (ICC-IF): Secreted.
- Human Protein Atlas. PAPPA antibody validation summary (2 antibodies).
- Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma in vitro and in vivo. Oncoimmunology 2017 — PMC5353903.
- Effects of Cyanobacterial Harmful Algal Bloom Toxin Microcystin-LR on Gonadotropin-Dependent Ovarian Follicle Maturation and Ovulation in Mice. Environmental health perspectives 2023 — PMC10284350.
- Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression. Bioengineered 2022 — PMC8805841.
- Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion. Oncotarget 2015 — PMC4599249.
- PubMed PMID:8620868 — UniProt-cited evidence.
- PubMed PMID:15164053 — UniProt-cited evidence.
- PubMed PMID:15489334 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for PAPPA (Pappalysin-1). Expected localisation Trophoblast cytoplasm (HPA tissue IHC); secreted (UniProt). Antigen retrieval: Citrate pH 6.0 HIER, 95–98 °C, 20 min (rule: cytoplasmic / membrane antigen). Validated IHC antibody: PB9306 at 0.5-1μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Placenta (Syncytiotrophoblasts - cell body); negative Adipose tissue. IHC workflow; specimen preparation unspecified. Protocol steps: 1. Sample: Tissue sections; selected-image fixative not specified (standard IHC workflow); 2. Fixation: Image fixative and duration unreported (datasheet PB9306); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat-induced epitope retrieval in citrate buffer, pH 6.0 , 20 min at 95–98 °C…; 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% normal serum of the secondary host, 30 min , room temperature (standard); 8. Primary antibody: Rabbit anti-PAPPA, 0.5-1μg/ml (datasheet PB9306); 9. Primary incubation: Overnight at 4 °C (standard). Watch for: Fixation: Keep fixation conditions consistent across sections. (standard IHC practice; not target-specific); Caveat: Protein and RNA locations may differ for secreted PAPPA (HPA tissue IHC); Isoform / epitope: No listed isoforms; mature chain starts at aa 82 (UniProt); Regulation: High in placenta and pregnancy serum (UniProt). Evidence: UniProt Q13219, HPA tissue IHC · Enhanced, HPA ICC-IF · Secreted, Datasheet PB9306, PMC5353903, PMC10284350. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/PAPPA/immunohistochemistry-ihc-guide.